Bank of America’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-206,500
| Closed | -$15.6M | – | 7559 |
|
|
2025
Q3 | $15.6M | Sell |
206,500
-11,500
| -5% | -$788K | ﹤0.01% | 2848 |
|
|
2025
Q2 | $15M | Buy |
218,000
+23,800
| +12% | +$1.56M | ﹤0.01% | 2839 |
|
|
2025
Q1 | $13.2M | Buy |
194,200
+173,200
| +825% | +$10.4M | ﹤0.01% | 2866 |
|
|
2024
Q4 | $943K | Sell |
21,000
-491,100
| -96% | -$27.6M | ﹤0.01% | 5077 |
|
|
2024
Q3 | $32.2M | Buy |
512,100
+471,500
| +1,161% | +$27.5M | ﹤0.01% | 1950 |
|
|
2024
Q2 | $2.4M | Sell |
40,600
-25,900
| -39% | -$1.62M | ﹤0.01% | 4302 |
|
|
2024
Q1 | $5.3M | Sell |
66,500
-5,700
| -8% | -$435K | ﹤0.01% | 3560 |
|
|
2023
Q4 | $5.7M | Sell |
72,200
-40,000
| -36% | -$2.85M | ﹤0.01% | 3452 |
|
|
2023
Q3 | $7.83M | Buy |
112,200
+30,200
| +37% | +$2.14M | ﹤0.01% | 2974 |
|
|
2023
Q2 | $5.67M | Sell |
82,000
-77,500
| -49% | -$5.51M | ﹤0.01% | 3281 |
|
|
2023
Q1 | $11.9M | Sell |
159,500
-108,100
| -40% | -$9.06M | ﹤0.01% | 2654 |
|
|
2022
Q4 | $24.9M | Buy |
267,600
+103,600
| +63% | +$10M | ﹤0.01% | 1828 |
|
|
2022
Q3 | $15.6M | Buy |
164,000
+102,600
| +167% | +$10.2M | ﹤0.01% | 2172 |
|
|
2022
Q2 | $5.69M | Buy |
61,400
+25,500
| +71% | +$2.49M | ﹤0.01% | 3262 |
|
|
2022
Q1 | $3.63M | Buy |
35,900
+31,100
| +648% | +$3.27M | ﹤0.01% | 3968 |
|
|
2021
Q4 | $495K | Sell |
4,800
-3,900
| -45% | -$360K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $738K | Buy |
8,700
+300
| +4% | +$25.1K | ﹤0.01% | 5334 |
|
|
2021
Q2 | $701K | Hold |
8,400
| – | – | ﹤0.01% | 5177 |
|
|
2021
Q1 | $632K | Sell |
8,400
-2,500
| -23% | -$182K | ﹤0.01% | 5185 |
|
|
2020
Q4 | $745K | Sell |
10,900
-200
| -2% | -$13K | ﹤0.01% | 4724 |
|
|
2020
Q3 | $649K | Buy |
11,100
+400
| +4% | +$24.9K | ﹤0.01% | 4521 |
|
|
2020
Q2 | $695K | Sell |
10,700
-700
| -6% | -$44.1K | ﹤0.01% | 4384 |
|
|
2020
Q1 | $676K | Sell |
11,400
-2,000
| -15% | -$134K | ﹤0.01% | 4291 |
|
|
2019
Q4 | $995K | Buy |
13,400
+3,100
| +30% | +$218K | ﹤0.01% | 4516 |
|
|
2019
Q3 | $650K | Sell |
10,300
-7,400
| -42% | -$439K | ﹤0.01% | 4886 |
|
|
2019
Q2 | $964K | Hold |
17,700
| – | – | ﹤0.01% | 4593 |
|
|
2019
Q1 | $955K | Hold |
17,700
| – | – | ﹤0.01% | 4553 |
|
|
2018
Q4 | $1.16M | Sell |
17,700
-300
| -2% | -$22.4K | ﹤0.01% | 4283 |
|
|
2018
Q3 | $1.42M | Buy |
+18,000
| New | +$1.29M | ﹤0.01% | 4245 |
|
|
2018
Q2 | – | Sell |
-1,000
| Closed | -$62K | – | 7113 |
|
|
2018
Q1 | $62K | Buy |
1,000
+800
| +400% | +$57.4K | ﹤0.01% | 5951 |
|
|
2017
Q4 | $15K | Hold |
200
| – | – | ﹤0.01% | 6501 |
|
|
2017
Q3 | $16K | Buy |
+200
| New | +$15.8K | ﹤0.01% | 6359 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$16K | – | 7006 |
|
|
2016
Q4 | $16K | Hold |
200
| – | – | ﹤0.01% | 6419 |
|
|
2016
Q3 | $18K | Buy |
+200
| New | +$18.9K | ﹤0.01% | 6165 |
|
|
2015
Q1 | – | Sell |
-16,800
| Closed | -$1.62M | – | 7142 |
|
|
2014
Q4 | $1.62M | Buy |
16,800
+2,600
| +18% | +$229K | ﹤0.01% | 3595 |
|
|
2014
Q3 | $1.13M | Buy |
14,200
+1,400
| +11% | +$110K | ﹤0.01% | 3893 |
|
|
2014
Q2 | $965K | Buy |
12,800
+400
| +3% | +$30.2K | ﹤0.01% | 4005 |
|
|
2014
Q1 | $928K | Sell |
12,400
-22,200
| -64% | -$1.57M | ﹤0.01% | 3981 |
|
|
2013
Q4 | $2.48M | Buy |
34,600
+22,600
| +188% | +$1.45M | ﹤0.01% | 3114 |
|
|
2013
Q3 | $681K | Buy |
12,000
+2,500
| +26% | +$149K | ﹤0.01% | 4337 |
|
|
2013
Q2 | $543K | Buy |
+9,500
| New | +$550K | ﹤0.01% | 4672 |
|
Other funds holding CVS
VCM
VPM
Bank of America's CVS Position: Q1 2026 in Review
Bank of America reduced its CVS Health (CVS) stake by 0.72% in Q1 2026, selling an estimated $5.21M and leaving 9,351,969 shares worth $672M. The position accounts for 0.05% of the portfolio, ranked #329.
Bank of America first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.8B in Q3 2022. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Bank of America held 9,351,969 shares of CVS Health worth $672M as of Q1 2026.
- Bank of America sold 67,667 CVS Health shares in Q1 2026, an estimated $5.21M.
- CVS Health made up 0.05% of Bank of America's portfolio in Q1 2026, its #329 holding.
- Bank of America first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Bank of America's CVS Health position peaked at $1.8B in Q3 2022.
- 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.